Original Article

Modern Pathology (2008) 21, 491–497; doi:10.1038/modpathol.2008.8; published online 1 February 2008

Malignant transformation of hepatic adenomas

Shien T L Micchelli1, Perumal Vivekanandan1, John K Boitnott1, Timothy M Pawlik2, Michael A Choti2 and Michael Torbenson1

  1. 1Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
  2. 2Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA

Correspondence: Dr M Torbenson, MD, Department of Pathology, The Johns Hopkins University School of Medicine, 1503 East Jefferson, Room B314, Baltimore, MD 21231, USA. E-mail: mtorben@jhmi.edu

Received 12 March 2007; Revised 16 June 2007; Accepted 18 June 2007; Published online 1 February 2008.

Top

Abstract

Hepatic adenomas are benign neoplasms of the liver that occur in several well-defined clinical settings, but principally that of excess hormone exposure. They have a small but poorly characterized risk of malignant degeneration. The clinical presentation and pathological findings were reviewed for all hepatic adenomas resected between January 1, 2003 and July 1, 2006. Immunohistochemistry for p53, beta-catenin and alpha-fetoprotein (AFP) were performed on those cases with malignant transformation and exon 3 of beta-catenin was amplified and sequenced. A total of 17 hepatic adenomas were resected and 3 showed malignant transformation. All three cases were in women with an age range of 23–33 years. The clinical presentations were vague abdominal pain. Histologically, the malignant transformation occurred within otherwise typical hepatic adenomas. Two of three cases showed patchy atypia throughout the hepatic adenoma. The hepatocellular carcinoma arose as distinct nodules directly within the adenomas, effectively ruling out synchronous lesions. The hepatocellular carcinomas were unifocal in two cases and multifocal in one case with the greatest dimensions of the hepatocellular carcinoma being 2.5, 2.2, and 1 cm. Immunostains for AFP and beta-catenin were negative in both the hepatic adenomas and areas of hepatocellular carcinoma. p53 immunostaining was positive within the areas of malignant transformation in one case. No mutations or deletions were seen in exon 3 of the beta-catenin gene for either the adenomas or the carcinoma. In conclusion, two of the cases that developed hepatocellular carcinomas showed cytological atypia in the background adenoma. The hepatocellular carcinomas arose as distinct nodules within the adenomas. No common molecular pathway of hepatocellular carcinogenesis was observed by examining AFP, beta-catenin, and p53 immunostains and no beta-catenin mutations or deletions were found.

Keywords:

hepatic adenoma, hepatocellular carcinoma, beta-catenin

Extra navigation

.

naturejobs

ADVERTISEMENT